ArticleTranslational gastroenterology and hepatology2026

Tobevibart plus elebsiran for the treatment of hepatitis D: how should we read the phase 2 data?

Tatyana Kushner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.